Literature DB >> 19337633

HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C.

Mircea Grigorescu1.   

Abstract

AIM: To investigate the HCV genotype distribution in Romania in the first national study, to establish the correlations with epidemiological, biochemical, virological and histological features and to compare our results with those from neighboring countries. PATIENTS AND METHODS: Two distinct groups of patients and two methods were used: 153 patients in the frame of ACHIEVE study with genotyping and subtypes determination (Versant HCV genotype 2.0 assay) and 461 patients in the frame of an Epidemiological National Multicenter Study having only genotype determination with a commercial kit (Roche Molecular System). Epidemiological, biochemical, virological and histological features were investigated only in the ENMS group.
RESULTS: Genotype 1b was found in 93.46% (ACHIEVE study) and genotype 1 (without subtype identification) in 99.13% of patients (ENMS study). Percutaneous routes of transmission were found in 85.9% of cases. The prevalence of HCV infection increased with age. A high viral load (> or = 600,000 IU/ml) was found in 67.9% of patients, especially those older than 40 years. Significant fibrosis > or = F2 was present in patients older than 40 years (70.9%). There were no correlations between HCV-RNA levels and histological features or between ALT levels and METAVIR activity or fibrosis scores. A similar homogeneity of HCV genotype distribution has been reported for Moldavia (96%) and Hungary (94.5%).
CONCLUSIONS: Type 1 HCV genotype was found almost exclusively in Romanian patients with chronic hepatitis C by two different methods of investigation. The pattern showed by this distribution in Romania and some neighboring countries suggests an epidemic profile of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337633

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  7 in total

1.  Update in infectious diseases.

Authors:  Victoria Arama; Ioana D Olaru
Journal:  Maedica (Buchar)       Date:  2011-10

2.  HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.

Authors:  Camelia Sultana; Codruta Vagu; Aura Temereanca; Camelia Grancea; Josefina Slobozeanu; Simona Ruta
Journal:  Cent Eur J Med       Date:  2011-10

Review 3.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

4.  The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C.

Authors:  Ioan Sporea; Alina Popescu; Manuela Curescu; Roxana Sirli; Isabel Dan; Adrian Goldis; Oana Gradinaru; Melania Ardelean; Mirela Danila; Simona Bota; Alexandra Deleanu
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

Review 5.  Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence?

Authors:  Simona Valean; Romeo Chira; Dan Dumitrascu
Journal:  Clujul Med       Date:  2018-10-30

6.  Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.

Authors:  Simona Paraschiv; Leontina Banica; Ionelia Nicolae; Iulia Niculescu; Adrian Abagiu; Raluca Jipa; Andrea-Clemencia Pineda-Peña; Marta Pingarilho; Emil Neaga; Kristof Theys; Pieter Libin; Dan Otelea; Ana Abecasis
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

7.  Host immune response in chronic hepatitis C infection: involvement of cytokines and inflammasomes.

Authors:  Mihail Virgil Boldeanu; Isabela Siloşi; Andreea Lili Bărbulescu; Raluca Elena Sandu; Cristiana Geormăneanu; Vlad Pădureanu; Mircea Vasile Popescu-Drigă; Ioan Sabin Poenariu; Cristian Adrian Siloşi; Anca Marilena Ungureanu; Anda Lorena Dijmărescu; Lidia Boldeanu
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.